Digital mammography promise fails to materialise
This article was originally published in Clinica
Full-field digital mammography, the long-promised replacement for conventional mammography systems, has still to reach the US market, more than 18 months after the first FDA submission was made.
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.